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Introduction: Although laparoscopic cholecystectomy appears to be less traumatic to the patients than
open surgery, decreased venous return from lower extremities and hypercoagulability occurring in
patients undergoing elective laparoscopic cholecystectomy with CO2 pneumoperitoneum makes it
a potent risk factor for deep venous thrombosis.
Methods: The observational study of 50 patients undergoing elective laparoscopic cholecystectomy was
designed to study alteration in PT, APTT, D-dimer and antithrombin III, which were measured preoper-
atively, 6 and 24 h postoperatively. It was accompanied by color duplex ultrasound of bilateral lower
limbs preoperatively and 7th day postoperatively to look for evidence of deep venous thrombosis.
Results: Signiﬁcant postoperative decrease in APTT and antithrombin III suggested activation of coagu-
lation while decrease in D-dimer suggested activation of ﬁbrinolysis. Values of PT had no statistically
signiﬁcant postoperative changes. Age, body mass index and duration of pneumoperitoneumwere found
to correlate with signiﬁcant activation of coagulation and ﬁbrinolysis. None of the patients developed
clinical or radiological evidence of deep venous thrombosis in the postoperative period.
Conclusions: CO2 pneumoperitoneum enhances the activation of coagulation and ﬁbrinolysis associated
with laparoscopic cholecystectomy. Patients with risk factors like old age, obesity or with expected long
duration of laparoscopic surgery are likely to have signiﬁcant activation of coagulation, making them
a vulnerable risk group for development of postoperative deep vein thrombosis, warranting some form of
thromboprophylaxis.
 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Approximately 15 years of experience and tens of thousands of
cases have led to a strong knowledge base for advance laparoscopy.
But our experience with and understanding of the effects of CO2
pneumoperitoneum are far from nascent.1
Much has still to be learned however, concerning the patho-
physiology and systemic complications of laparoscopic surgery.
It has long been known that a hypercoagulability state develops
after surgery. Theadvantageof laparoscopic cholecystectomyover the
open procedure seems to be related to the reduced surgical trauma.
Patients who undergo laparoscopic cholecystectomy are operated on
under general anesthesia, in a reverse Trendelenburg position withmu Bhanja, Aligarh 202001,
7562.
rg).
ciates Ltd. Published by Elsevier Ltcapnoperitoneum. All of these factors can induce venous stasis in the
lower extremities,which in associationwith alteration in coagulation
proﬁle may lead to postoperative deep vein thrombosis.
A number of factors pertaining to the surgical technique may be
relevant to the pathophysiology of the hypercoagulable state. First,
the pneumoperitoneum and reverse Trendelenburg position of the
patient during surgerymay lead to venous stasis in the legs. Second
it may further be speculated that this venous stasis could affect the
endothelium and induce measurable changes in coagulation and
ﬁbrinolysis. All three elements of Virchow’s triad are present and
thus the potential exists for thromboembolic complications.
The reported incidence of postoperative DVT in laparoscopic
cholecystectomy varies considerably between 0 and 55%.2 The
only ﬁrm conclusion from this variability in incidence is that
further studies are needed.
This study aims to assess the degree of postoperative changes in
coagulation proﬁle and to look for evidence of thrombosis in deepd. All rights reserved.
Table 1
Perioperative changes in measures parameters of coagulation and ﬁbrinolysis.
Coagulation parameters Sample
Preoperative 6 h Postoperative
(p value)
24 h Postoperative
(p value)
PT 1.01 0.2 0.99 4.74 (0.06) 0.99 4.65 (0.07)
APTT 1.01 0.01 0.91 0.04 (0.00) 0.95 0.03 (0.00)
D-Dimer 166 30.49 416.70 119.25 315.26 83.86
Anti thrombin III 91.5 4.07 74.6 8.13 (0.00) 79.4 7.99 (0.00)
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scopic cholecystectomy with CO2 pneumoperitoneum.
2. Materials and methods
2.1. Study design and patient eligibility
A prospective observational study was conducted which
enrolled 50 patients over the age of 18 years with ASA grade I and II
scheduled for elective laparoscopic cholecystectomy for symp-
tomatic gall stone disease. Before entry into the study, informed
consent was obtained from all patients. Patients were excluded
from the study if they had acute cholecystitis, cholangitis, acute
pancreatitis or other acute inﬂammation. Patients with recent
(6 months) surgery, recurrent or recent (<2 years) malignancy and
current or recent (6 months) thromboembolic disease, hemato-
logical disorder, renal, hepatic, rheumatic or vascular disease
(except arteriosclerosis) were excluded from the study. Patients
with pregnancy or on anticoagulant treatment including aspirin or
on oral contraceptives or danazol were also not included in the
study.
2.2. Operative technique and postoperative care
Laparoscopic cholecystectomy was performed by the same
surgical and anesthesiologist team in all patients. Antithrombotic
prophylaxis was not given to any of the patients. Laparoscopic
cholecystectomy was performed with conventional carbon dioxide
pneumoperitoneum at a pressure of 12 mmHg using two 10 mm
and two 5 mm trocars and 30 reverse Trendelenburg position.
Intraabdominal pressure was maintained at 12 mmHg. Antibiotic
prophylaxis was not given as per unit protocol. Intraabdominal
drains were not placed in any of the patients. All patients were
extubated and transferred to the surgical ward postoperatively.
Patients were encouraged to ambulate 24 h after the operation and
were discharged after 48 h. All patients recovered well and had an
uneventful postoperative course without any complication or
death.
2.3. Blood collection and processing
Blood samples were taken preoperatively, 6 h after surgery and
24 h after surgery. Venous blood was collected in 3.8% sodium
citrate at a ratio of nine parts blood to one part anticoagulant (1:10
ratio). Blood was centrifugedwithin 30 min and plasmawas kept at
80 C until analysis.
2.4. Biochemical assays
The coagulation and ﬁbrinolytic proﬁles were obtained by
determining the plasma prothrombin time (PT), activated partial
thromboplastin time (APTT), antithrombin III and D-dimer value.
The PT was expressed accurately in terms of the International
Normalized Ratio (INR). The APTT was also expressed as the ratio of
patient to test control value. The antithrombin III activity was
expressed as percent value of the control activity and its
measurement was made by a chromogenic assay. The D-dimer
measurement was based on the enzyme immunoassay method and
expressed in nanograms per milliliter.
2.5. Radiographic intervention
Duplex ultrasound combining real time Bmode ultrasound with
pulsed Doppler capability and color ﬂow imaging was donepreoperatively and on the seventh postoperative day to detect
evidence of thrombosis in deep veins of the lower limbs.
2.6. Statistical analysis
Results were expressed as mean value  SD. Wilcoxon sign rank
tests were used to evaluate signiﬁcant differences from baseline
values within each group and Pearson correlation was used to
assess the signiﬁcance between two groups at each time point.
A p value of less than 0.05 was considered signiﬁcant.
3. Results
3.1. Patients demographic and operative data
Age of patients varied from 18 to 65 years with six male patients
(12%) and 44 female patients (88%). The mean age in years was
36.0  10.7. The body mass index of patients varied from 21 to
29.6 kg/m2. The mean body mass index was 24.09  1.99. The
duration of pneumoperitoneum varied from 40 to 130 min with
a mean of 74.20  19.57 min.
3.2. Markers of coagulation and ﬁbrinolysis
The plasma levels of the monitored parameters for the patients
were altered (Table 1), thus registering activation of the coagulation
process. PT did not show any signiﬁcant operative variation both at
6 and 24 h postoperatively compared to the preoperative value.
APTT, D-dimer and AT III showed statistically signiﬁcant variation
both at 6 and 24 h postoperatively.
Age, body mass index and duration of pneumoperitoneumwere
correlated with percent change in studied coagulation parameters
both at 6 and 24 h postoperatively. There was no signiﬁcant peri-
operative variation in PT and APTT at 6 and 24 h postoperatively.
However, D-dimer and AT III showed signiﬁcant perioperative
variation in PT and APTT both at 6 and 24 h postoperatively in
relation to age, sex and duration of pneumoperitoneum.
3.3. Prothrombin time
The mean prothrombin time preoperatively was 1.01  0.2 INR,
which decreased to 0.99  4.74 INR, 6 h postoperatively, and
0.99  4.65 INR, 24 h postoperatively. This postoperative change
was found to be non-signiﬁcant statistically (p value ¼ 0.06 and
0.07 respectively). Age, body mass index and duration of pneu-
moperitoneum were correlated with percent change in
prothrombin time both at 6 and 24 h postoperatively. There was no
signiﬁcant correlation between age and percent change in
prothrombin time at either point of time (p value ¼ 0.88 at 6 h and
0.35 at 24 h postoperatively). There was no signiﬁcant correlation
between body mass index and percent change in prothrombin time
at either point of time (p value ¼ 0.98 at 6 h and 0.86 at 24 h
postoperatively). There was no signiﬁcant correlation between
duration of pneumoperitoneum and percent change in
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0.39 at 24 h postoperatively).
3.4. Activated partial thromboplastin time
The mean activated partial thromboplastin time preoperatively
was 1.01  0.01 min, which decreased to 0.91  0.04 min 6 h post-
operatively and 0.95  0.03 min 24 h postoperatively. This post-
operative change was found to be signiﬁcant (p value ¼ 0.000).
Age, body mass index and duration of pneumoperitoneumwere
correlated with percent change in activated partial thromboplastin
time both at 6 and 24 h postoperatively. There was no signiﬁcant
correlation between age and percent change in activated partial
thromboplastin time at either point of time (p value ¼ 0.50 at 6 h
and 0.09 at 24 h postoperatively). There was signiﬁcant correlation
between body mass index and percent change in activated partial
thromboplastin time at 6 h postoperatively (p value ¼ 0.04) but not
at 24 h postoperatively (p ¼ 0.43). There was no signiﬁcant corre-
lation between duration of pneumoperitoneum and percent
change in activated partial thromboplastin time at either point of
time (p value ¼ 0.21 at 6 h and 0.37 at 24 h postoperatively).
3.5. Antithrombin III
The mean antithrombin III preoperatively was 91.5  4.07%,
which decreased to 74.6  8.13% 6 h postoperatively and
79.4  7.99% 24 h postoperatively This postoperative change was
found to be signiﬁcant statistically (p value ¼ 0.000). Age, body
mass index and duration of pneumoperitoneum were correlated
with percent change in antithrombin III both at 6 and 24 h
postoperatively. There was signiﬁcant correlation between age
and percent change in antithrombin III at both points of time
(p value ¼ 0.04 at 6 h and p ¼ 0.002 at 24 h postoperatively).
Body mass index was correlated with percent change in anti-
thrombin III both at 6 h postoperatively and at 24 h post-
operatively. There was signiﬁcant correlation between body mass
index and percent change in antithrombin III at both points of time
(p value ¼ 0.000 at 6 h and p ¼ 0.000 at 24 h postoperatively).
Duration of pneumoperitoneum was correlated with percent
change in antithrombin III both at 6 h postoperatively and at 24 h
postoperatively. There was signiﬁcant correlation between age and
percent change in antithrombin III at both points of time
(p value ¼ 0.008 at 6 h and p ¼ 0.018 at 24 h postoperatively).
3.6. D-Dimer
The mean D-dimer preoperatively was 166  30.49 ng/ml,
which increased to 416.70  119.25 ng/ml 6 h postoperatively and
315.26  83.86 ng/ml 24 h postoperatively This postoperative
change was found to be signiﬁcant statistically (p value ¼ 0.000).
Age, body mass index and duration of pneumoperitoneum were
correlated with percent change in D-dimer both at 6 and 24 h
postoperatively. There was signiﬁcant correlation between age and
percent change in D-dimer at both points of time (p value ¼ 0.04 at
6 h and p ¼ 0.002 at 24 h postoperatively). Body mass index was
correlated with percent change in D-dimer both at 6 h post-
operatively and at 24 h postoperatively. There was signiﬁcant
correlation between body mass index and percent change in
D-dimer at both points of time (p value ¼ 0.000 at 6 h and p ¼ 0.000
at 24 h postoperatively). Duration of pneumoperitoneum was
correlated with percent change in D-dimer both at 6 h post-
operatively and at 24 h postoperatively. There was signiﬁcant
correlation between age and percent change in D-dimer at both
points of time (p value ¼ 0.008 at 6 h and p ¼ 0.018 at 24 h
postoperatively).3.7. Color duplex imaging of bilateral lower limbs
Patients were subjected to color duplex imaging of bilateral
lower limbs on the 7th postoperative day to look for any evidence of
deep vein thrombosis. None of the patients showed evidence of
deep vein thrombosis on color duplex imaging.
4. Discussion
Its exceptionally fast acceptance, both by patients and surgeons,
meant that laparoscopic surgery was introduced without much
scientiﬁc evidence to support its safety. Surgeons seemed to spend
the ﬁrst years trying to increase their own experience by per-
forming as many procedures as possible.
Most publications regarding laparoscopic cholecystectomy
during the early 1990s were retrospective reports of personal or
institutional experience with the operation. In most reports, data
on complications were included, but whether complications were
actively looked for or case-notes just checked retrospectively was
not mentioned.
A few reports are available regarding levels of one or more of the
presently relevantmarkers in patients undergoing cholecystectomy
and only some of these studies have compared laparoscopic
cholecystectomy with open cholecystectomy.
A comparative study between open and laparoscopic cholecys-
tectomy could not be undertaken as laparoscopic cholecystectomy
is the standard procedure. Thus it would not be ethical to operate
on patients using the open cholecystectomy technique for research
purposes.
4.1. Markers of coagulation and ﬁbrinolysis
Prothrombin time is a measure of coagulation, which evaluates
extrinsic pathway (factor VII) and common pathway protein factors
(ﬁbrinogen, prothrombin, Factor V and X). Therewas no statistically
signiﬁcant perioperative decrease in PT (p value > 0.05) in our
study that could indicate hypercoagulability. Activated partial
prothrombin time is a direct measure of coagulation, which tests
the intrinsic pathway (factor XII, XI, IX, VIII) and abovementioned
common pathway factors. Our study shows statistically signiﬁcant
(p value ¼ 0.000) perioperative decrease in APTT, which suggests
activated coagulation. Thrombin, an enzyme with weak proteolytic
activity, acts to convert ﬁbrinogen into ﬁbrin ﬁbers that enmesh
platelets, blood cells, and plasma to ﬁnally form the clot. One of the
primary down-regulators of the coagulation cascade is anti-
thrombin III, which exerts its down-regulatory effect through the
inactivation of several activated factors, including factors X, IX, XII
and thrombin. By inactivating the numbered factors, thrombin
production is reduced. Antithrombin also binds with thrombin and
thereby blocks thrombin’s interaction with ﬁbrinogen. Our study
shows a statistically signiﬁcant perioperative decrease in anti-
thrombin III (p value ¼ 0.000), which shows a state of hypercoag-
ulability. D-Dimer levels have been used as amarker of intravascular
clot formation. D-Dimer is a cross-linked ﬁbrin degradation
product, which forms as a result of a breakdown of ﬁbrin. D-Dimer
levels are frequently increased after surgery or trauma and indicate
the presence of an intravascular clot that has undergone lysis.
Our study shows a statistically signiﬁcant (p value ¼ 0.000)
perioperative increase in D-dimer levels, which suggests formation
of intravascular clot. The observed decreases in PTT and anti-
thrombin III indicate an activated coagulation. The increase in
D-dimer indicates that both coagulation and ﬁbrinolysis are acti-
vated, since it is the end product of the degradation of ﬁbrin, which
has to have been formed by coagulation in the ﬁrst phase. Increased
coagulation activity is commonly seen after surgery and can be
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therefore difﬁcult to know what is caused by the pneumo-
peritoneum and what is caused by the surgical procedure itself. In
a comparison of laparoscopic cholecystectomy using CO2 pneu-
moperitoneum with gasless laparoscopic cholecystectomy using
lifting devices, Larsen et al3 demonstrated that there were no
differences between the two groups in fragment 1 þ 2, soluble
ﬁbrin or D-dimer, suggesting CO2 pneumoperitoneum does not
enhance the activation of coagulation and ﬁbrinolysis associated
with laparoscopic cholecystectomy.
Lauro et al.4 also suggested that, perioperatively; the coagu-
lative-ﬁbrinolytic changes are lower in laparoscopic than in open
cholecystectomy . While in a comparison of laparoscopic and open
gastric bypass, Nguyen et al.5 demonstrated there were similar
increases in fragment 1 þ 2, TAT and ﬁbrinogen, whereas the
D-dimer increase was lower in the laparoscopic group during the
ﬁrst 24 h. They suggested laparoscopic gastric bypass induces
a hypercoagulable state similar to open group and DVT prophylaxis
should be given during laparoscopic gastric bypass. Vecchio et al.6
showed signiﬁcant perioperative increase in ﬁbrinogen, beta
thromboglobulin and D-dimer, suggesting laparoscopic cholecys-
tectomy induces activation of coagulation and ﬁbrinolysis. There-
fore, they recommended routine thromboembolic prophylaxis in
patients undergoing laparoscopic surgery. Caprini et al.7 reported
amarked hypercoagulable state after laparoscopic cholecystectomy
as seen by an increase in thromboelastographic index and decrease
in partial prothrombin time, on the ﬁrst postoperative day
compared with preoperative values.
Fibrinolysis activation could counteract the increase in coagula-
tion activity, and the increase in D-dimer found inour study indicates
that this may be the case. Martinez-Ramos et al.8 found a greater
increase in ﬁbrinolytic activity after laparoscopic cholecystectomy
than after an open operation of similar duration (Bassini hernior-
rhaphy), and also a greater increase in tPA in the laparoscopic
cholecystectomy group with no changes in PAI-1. Vander Velpen
et al.9 found similar increases in tPA and PAI-1 after open chole-
cystectomy and laparoscopic cholecystectomy, with a trend toward
a higher ﬁbrinolysis inhibition early postoperatively in the open
cholecystectomy group. A signiﬁcant increase in PAI-1 in the open
cholecystectomy group with no change in the laparoscopic chole-
cystectomy group has also been found in other studies. Rahr et al.10
also found no changes in tPA or PAI-1 levels in a comparison of pre-
and postoperative values in laparoscopic cholecystectomy patients,
except for a transient increase in tPA activity during the operation.
So, the available literature is contradictory, but the majority of
studies seem to indicate activation of coagulation and higher acti-
vation or lower inhibition of ﬁbrinolysis in patients undergoing
laparoscopic compared to open cholecystectomy.
In our study, we tried to correlate markers of activation of coag-
ulation and ﬁbrinolysis with known risk factors of deep vein throm-
bosis.11 No previous study to date has studied such types of
correlation. We did not ﬁnd any correlation of percent change in
prothrombin time or activated partial prothrombin time with age,
body mass index or duration of pneumoperitoneum. We found
positive correlations betweenpercent change in antithrombin III and
D-dimer with age, BMI and duration of pneumoperitoneum, which
suggest a signiﬁcant hypercoagulable state with old age, obesity and
duration of surgery. These correlations seem to indicate that age,
obesity and duration of pneumoperitoneum should be considered as
risk factors for activation of coagulation and ﬁbrinolysis.
5. Deep venous thrombosis in laparoscopic cholecystectomy
None of the patients in our study showed any evidence of deep
vein thrombosis in our study when they were subjected to bilateralcolor duplex imaging of bilateral lower limbs on the 7th post-
operative day, despite the fact that none of the patients were given
any form of thromboprophylaxis. The frequency of postoperative
DVT in laparoscopic cholecystectomy varies from 0 to 55% in the
few studies that have been published. Blake et al.12 reported 0%
incidence of DVT in patients undergoing laparoscopic cholecys-
tectomy. Five-hundred and eighty-seven patients participated in
their study out of which only 18 patients were given any form of
prophylaxis. The ﬂaw in their study was the method of evaluation
for DVT, which was clinical examination. Wazz et al.13 also reported
0% incidence of DVT in patients undergoing laparoscopic chole-
cystectomy. Sixty-one patients participated in their study. No
patient was given any form of thromboprophylaxis. Patients
underwent color duplex evaluation of bilateral lower limbs
preoperatively and on the 1st postoperative day. Bounamaeux
et al.14 also reported 0% incidence of DVT in patients undergoing
laparoscopic cholecystectomy. Forty patients participated in their
study. Twenty-ﬁve patients were given low molecular weight
heparin and 15 patients were not given any form of thrombopro-
phylaxis. Patients underwent bilateral pedal venography on the
6–10th postoperative day to look for evidence of DVT. Caprini et al.7
reported 1% incidence of DVT in patients undergoing laparoscopic
cholecystectomy. One-hundred patients participated in their study.
Patients were given graduated compression stockings and
sequential compression. Twenty-six patients were also given low
molecular weight heparin. Patients underwent bilateral color
duplex imaging on the 7th postoperative day to look for evidence of
DVT. Lord et al.15 reported 1.7% incidence of DVT in patients
undergoing laparoscopic cholecystectomy. One-hundred patients
participated in their study. Patients were given graduated
compression stockings and preoperative intermittent calf
compression. Patients underwent bilateral color duplex imaging
preoperatively, 1st postoperative day and at 2–4 weeks to look for
evidence of DVT. Contrary to these studies, Krasinski et al.16
reported a high incidence of DVT to the tune of 47% in patients
undergoing laparoscopic cholecystectomy. Forty patients partici-
pated in their study. Patients were given thromboprophylaxis in the
form of lowmolecular weight heparin. Patients underwent bilateral
color duplex imaging preoperatively, 2nd, 7th and 30th post-
operative day to look for evidence of DVT. Patel et al.2 found an
alarming incidence of 55% for venous thromboembolism in patients
who underwent laparoscopic cholecystectomy. Twenty patients
participated in their study. Patients were given thromboprophy-
laxis in the form of graduated compression stockings and preop-
erative electrical calf compression and pharmacological therapy.
Patients underwent bilateral color duplex imaging preoperatively,
1st, 7th and 30th postoperative day to look for evidence of DVT. The
highest numbers were found in small studies using duplex Doppler
investigations. Studies by Patel et al.2 and Krasinski et al.,16 which
reported maximum incidence of DVT in laparoscopic cholecystec-
tomy, involved only 20 and 40 patients respectively. Color duplex
imaging has been shown to have a signiﬁcant learning curve and to
have limitations in asymptomatic patients and those with isolated
calf vein thrombosis.17 Zero percent frequency of DVT found by
phlebography on postoperative days 7–11, as reported by Bouna-
maeux et al.,14 contradicts the ﬁndings by Patel et al.2 and Krasinski
et al.16 Seven out of the 11 thrombi found in the study by Patel et al.2
were found on postoperative day 1. In the other studies using color
duplex imaging, only Wazz et al.12 and Lord et al.15 studied their
patients earlier than on postoperative day 5. It is a possibility that
small thrombi could occur frequently in the ﬁrst postoperative
days, but that the early ambulation made possible by reduced
postoperative pain in laparoscopically operated patients may result
in early thrombolysis. The patients in Lord’s study received what
would seem to be a more than adequate prophylaxis against
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calf compression), which may explain the low frequency of DVT
(1.7%). The patients in the study by Wazz et al.,12 however, did not
receive any thromboembolism prophylaxis, and still no thrombi
were found, which is difﬁcult to explain in light of the results of
Patel et al.2 and Krasinski et al.16
In the light of these contradictory studies it can be concluded
that the sample sizes are generally small in these studies and the
timing of and number of examinations vary widely, as do the
results, which range from a reassuring 0% to a deeply disconcerting
55%. In a meta analysis of 60 series involving 153,832 patients
undergoing laparoscopic cholecystectomy, Lindberg et al.18
revealed an incidence of 0.03% for deep vein thrombosis and 0.06%
for pulmonary embolism, while all patients were given prophylaxis
against venous thromboembolism. The only ﬁrm conclusion one
can draw from these conﬂicting results is that further studies are
needed. Ikeda et al., in his study on incidence of portal or splenic
vein thrombosis after laparoscopic splenectomy, demonstrated
higher risk of postoperative portal or splenic vein thrombosis
in laparoscopic group as compared to open (55 vs 19%,
p value ¼ 0.03).17 They concluded one of the factors for higher
incidence of postoperative portal or splenic vein thrombosis in the
laparoscopic group may be pneumoperitoneum, which causes
coagulation activation as well as stasis of venous blood in portal
vein. Cubillana et al. reported a case of renal vein thrombosis
occurring in a patient after laparoscopic cholecystectomy.19 Several
factors could increase the rate of postoperative thromboembolic
complications in laparoscopically performed operations as
compared to open operations:
(1) Laparoscopic operations typically take longer than open
operations, at least until the surgeon has become experi-
enced in laparoscopic surgery. Longer duration of the
surgical procedure increases the risk of thromboembolic
complications.
(2) The pneumoperitoneum necessary for exposure during
laparoscopic operations can compress the inferior caval
vein, causing venous stasis in the lower body.
(3) The reverse Trendelenburg position required for proper
exposure of the operative ﬁeld during laparoscopic opera-
tions in the upper abdomen further reduces the venous
return from the lower body.
(4) Perioperative venous dilation has been implicated as one
factor of importance in the pathogenesis of postoperative
DVT, possibly by causing microscopic intimal tears and
causing platelet aggregation and activation of the coagula-
tion system although this is modiﬁed by an increase in
ﬁbrinolysis.
All three elements of Virchow’s triad are present and thus the
potential exists for thromboembolic complications.
Reduced postoperative pain after laparoscopic surgery, on the
other hand, quickens the mobilization of the patient after surgery,
which should reduce the risk of thromboembolic complications.
The net result of these contradictory factors is still debatable.
Our study indicates activation of coagulation and ﬁbrinolysis, as
shown by postoperative decrease in APTT and antithrombin and
increase in D-dimer. But no patient in our study had evidence of
deep vein thrombosis on color duplex imaging of bilateral lower
limbs. These observations suggest a low incidence of thrombosis in
the face of theoretical and laboratory evidence of postoperative
hypercoagulability. Fibrinolysis activation could counteract the
increase in coagulation activity, and the increase in D-dimer found
in our study indicates that this may be the case, which may explain
the low incidence of thrombosis.Furthermore, it is a possibility that small thrombi formed
initially in the postoperative period might have thrombolysed by
increased ﬁbrinolytic activity and so could not be visualized by
color Doppler done on the 7th postoperative day. It should also be
kept in mind that most studies including ours have used color
duplex imaging of bilateral lower limbs as a method to detect deep
vein thrombosis, which has only 63.5% sensitivity20 in detecting
distal deep vein thrombosis.6. Conclusions
Patients with risk factors like old age, obesity or with expected
long duration of laparoscopic surgery are likely to have signiﬁcant
activation of coagulation, making them a vulnerable risk group for
development of postoperative deep vein thrombosis, warranting
some form of thromboprophylaxis. Further studies with large
sample size and more sensitive means to detect distal calf vein
thrombosis like MR venography performed on postoperative day
one are required to support these ﬁndings.
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